US 9765139
Perfusion method for manufacturing etanercept
granted A61KA61K38/1793A61K47/68
Quick answer
US patent 9765139 (Perfusion method for manufacturing etanercept) held by Coherus BioSciences, Inc. expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Coherus BioSciences, Inc.
- Grant date
- Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/1793, A61K47/68, A61P, A61P37/00